Biotalys (EBR:BTLS), an Agricultural Technology (AgTech) company, has unveiled progress in its production capabilities for its first biocontrol product, Evoca™. The company’s scientists developed multiple proprietary yeast strains, improving the production efficiency of Evoca’s bioactive ingredient by 50 to 70% in a year. The company claims the improvement will bolster its path to market for its biocontrol products.
Evoca is a novel bio fungicide based on proteins developed from Biotalys’ technology platform, the AGROBODY Foundry™. The product helps control fungal diseases like Botrytis and Powdery Mildew in various crops (strawberries, grapes, and other high-end fruits and vegetables). Evoca has shown strong performance over 600 independent and company-driven field & greenhouse trials across various environments.
Yielded via fermentation in simple micro-organisms such as yeast, the company claims that Protein-based biocontrols such as Evoca can increase the production efficiency by 50 to 70% in only one year. As a result, Biotalys is further reducing production costs, clearing the path to a market entry that is economically viable for the growers, consumers, and the environment. Moreover, Biotalys is leveraging this significant improvement in the production of AGROBODY™ bioactive to increase its I.P. portfolio.
Subject to regulatory clearance by the U.S. Environmental Protection Agency (EPA), Evoca will initially be distributed in a handful of states in the U.S. as a product for market calibration. At the same time, a commercial version is expected for 2026. The company’s COO, Luc Maertens, stated that this milestone is a prevalent step forward in delivering effective and safe biocontrols to growers at viable pricing while generating commercial value for the company. The company plans to build on this achievement to further strategically expand its I.P. portfolio and develop Evoca and its pipeline of biocontrols manufactured via fermentation to substitute chemical pesticides based on fossil fuels.
Image provided by Biotalys
1 Comment
You must log in to post a comment.